Veldoreotide TFA
Veldoreotide TFA (DG3173) is a somatostatin receptor agonist with selectivity for SSTR2, 4, and 5. It demonstrates potent inhibition of growth hormone secretion in vitro and in vivo, showing superior efficacy to octreotide in pituitary adenoma models, which supports its research in endocrinology and oncology.
Product Specifications
CAS Number
2126831-23-8
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Smiles
C (C (O) =O) (F) (F) F.C (C=1C=2C (NC1) =CC=CC2) [C@H]3C (=O) N[C@H] (CC=4C=5C (NC4) =CC=CC5) C (=O) N[C@@H] (CCCCN) C (=O) N[C@@] ([C@@H] (C) O) (C (=O) N[C@@H] (CC6=CC=CC=C6) C (=O) N (CC (N) =O) CCCC (=O) NCCCC (=O) N[C@@H] (CC7=CC=CC=C7) C (=O) N3) [H]
Molecular Formula
C62H75F3N12O12
Molecular Weight
1237.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
Z06614-100 100 µg
HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer, His & Avi, Human
Sign In for Pricing
View Details